Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

NCT06694012 is registered in ClinicalTrials.gov with Osaka Metropolitan University as lead sponsor.

NCT NCT06694012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06694012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Lead sponsor
Osaka Metropolitan University
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2024
Completion date
March 31, 2050
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, central obesity, chronic kidney disease(ckd), diabetes mellitus, dyslipidemia, hepatic steatosis, hyperglycemia, hyperlipidemia, hypertension, hyperuricemia or gout, hyperuricemia, gout, insulin sensitivity/resistance, metabolic syndrome, obesity, obesity, abdominal, obesity/epidemiology, type 2 diabetes, type 2 diabetes mellitus (t2dm), visceral fat